ClinConnect ClinConnect Logo
Search / Trial NCT05541120

Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With Type 2 Diabetes

Launched by TRACY JALBUENA MD · Sep 14, 2022

Trial Information

Current as of August 11, 2025

Withdrawn

Keywords

Remote Patient Monitoring Glycemic Control

ClinConnect Summary

Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals with Type 2 Diabetes

Summary

ABSTRACT

In 2021, the MaineHealth Telehealth team was awarded a five-year, $1.7 million "Evidence-Based Telehealth Network Program" grant (EB TNPG) from Health Resources and Services Administration (HRSA). This grant is aimed at improving patient access to educational and management services for patients with type 2 diabetes in the rural Maine primary care setting by implementing RPM. The RPM devices will be used to transmit a participant's home...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be enrolled in Living Well with Diabetes education program
  • Have an HbA1c% ≥ 8 in the prior 6 months
  • Be capable of providing consent
  • Be adults (age 18 or over)
  • Exclusion Criteria:
  • Primarily managed by endocrinology for their diabetes (\> 1 visit with endocrinology in the previous 12 months)
  • Incarcerated
  • PCP not at one of the 30 primary care practices listed (see attachment List of PCP Practices)
  • Diagnosed with type 1 diabetes
  • Candidate for continuous glucose monitoring, as defined by Centers for Medicare and Medicaid Services as using at least three insulin injections per day, any combination of types of insulins
  • Pregnant
  • Have previously participated in the Living Well with Diabetes/Virtual Diabetes Self-Management Program
  • Have previously used a remote patient monitoring device for diabetes management
  • Have a diagnosis of dementia or other clinical diagnosis that would impair participation capacity
  • Currently participating in any other clinical trial regarding diabetes care or management
  • Currently enrolled in hospice
  • Currently residing in a long term care or rehabilitation facility

About Tracy Jalbuena Md

Dr. Tracy Jalbuena, MD, is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical practice and a focus on innovative therapeutic approaches, Dr. Jalbuena leads trials that address critical health challenges. Her expertise encompasses various therapeutic areas, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, Dr. Jalbuena aims to drive meaningful advancements in healthcare, ultimately translating research findings into practical treatments for patients.

Locations

Rockport, Maine, United States

Patients applied

0 patients applied

Trial Officials

Tracy Jalbuena, MD

Principal Investigator

MaineHealth

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials